InterventionsHuman trial

Liraglutide Ameliorates Diabetic Cardiomyopathy via Ferroptosis Inhibition: Clinical CMR Evidence and Mechanistic Insights

ADA Scientific Sessions 2026 Abstract

The paper

Lianqin Chen, Yingqi Lv, Yao Lin, Pei Yu

Tianjin

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Poster 1732-P

doi.org/10.2337/db26-1732-p

Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
Semaglutide improved heart artery function in pigs
Research Square · 8 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026